bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate

C105H105Cl2N15O16 — CID 159677170

IUPACbis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate
SMILESCCOC(=O)c1c(O)c2cnccc2n(Cc2ccc(OC)cc2)c1=O.COc1ccc(Cn2c(=O)c(C#N)c(Cl)c3cnccc32)cc1.COc1ccc(Cn2c(=O)c(C#N)c(Cl)c3cnccc32)cc1.COc1ccc(Cn2c(=O)c(C(=O)NC3CCCCC3)c(O)c3cnccc32)cc1.Cc1ccc(Cn2c(=O)c(C(=O)NC3CCCCC3)c(O)c3cnccc32)cc1.NC1CCCCC1
InChIInChI=1S/C23H25N3O4.C23H25N3O3.C19H18N2O5.2C17H12ClN3O2.C6H13N/c1-30-17-9-7-15(8-10-17)14-26-19-11-12-24-13-18(19)21(27)20(23(26)29)22(28)25-16-5-3-2-4-6-16;1-15-7-9-16(10-8-15)14-26-19-11-12-24-13-18(19)21(27)20(23(26)29)22(28)25-17-5-3-2-4-6-17;1-3-26-19(24)16-17(22)14-10-20-9-8-15(14)21(18(16)23)11-12-4-6-13(25-2)7-5-12;2*1-23-12-4-2-11(3-5-12)10-21-15-6-7-20-9-14(15)16(18)13(8-19)17(21)22;7-6-4-2-1-3-5-6/h7-13,16,27H,2-6,14H2,1H3,(H,25,28);7-13,17,27H,2-6,14H2,1H3,(H,25,28);4-10,22H,3,11H2,1-2H3;2*2-7,9H,10H2,1H3;6H,1-5,7H2
InChIKeyMUTBBYDOQYMWBX-UHFFFAOYSA-N
MW1903.99 g/mol
LogP16.31
Rot. Bonds20

About bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate

bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate (PubChem CID 159677170) has the molecular formula C105H105Cl2N15O16 and a molecular weight of 1903.99 g/mol. Its IUPAC name is bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate.

Molecular Properties

Compound Namebis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate
PubChem CID159677170
Molecular FormulaC105H105Cl2N15O16
Molecular Weight1903.99 g/mol
Exact Mass1901.72
IUPAC Namebis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate
SMILESCCOC(=O)c1c(O)c2cnccc2n(Cc2ccc(OC)cc2)c1=O.COc1ccc(Cn2c(=O)c(C#N)c(Cl)c3cnccc32)cc1.COc1ccc(Cn2c(=O)c(C#N)c(Cl)c3cnccc32)cc1.COc1ccc(Cn2c(=O)c(C(=O)NC3CCCCC3)c(O)c3cnccc32)cc1.Cc1ccc(Cn2c(=O)c(C(=O)NC3CCCCC3)c(O)c3cnccc32)cc1.NC1CCCCC1
InChIInChI=1S/C23H25N3O4.C23H25N3O3.C19H18N2O5.2C17H12ClN3O2.C6H13N/c1-30-17-9-7-15(8-10-17)14-26-19-11-12-24-13-18(19)21(27)20(23(26)29)22(28)25-16-5-3-2-4-6-16;1-15-7-9-16(10-8-15)14-26-19-11-12-24-13-18(19)21(27)20(23(26)29)22(28)25-17-5-3-2-4-6-17;1-3-26-19(24)16-17(22)14-10-20-9-8-15(14)21(18(16)23)11-12-4-6-13(25-2)7-5-12;2*1-23-12-4-2-11(3-5-12)10-21-15-6-7-20-9-14(15)16(18)13(8-19)17(21)22;7-6-4-2-1-3-5-6/h7-13,16,27H,2-6,14H2,1H3,(H,25,28);7-13,17,27H,2-6,14H2,1H3,(H,25,28);4-10,22H,3,11H2,1-2H3;2*2-7,9H,10H2,1H3;6H,1-5,7H2
InChIKeyMUTBBYDOQYMWBX-UHFFFAOYSA-N
XLogP16.31
TPSA430.16 Ų
H-Bond Donors6
H-Bond Acceptors29
Rotatable Bonds20
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001903.99
LogP ≤ 516.31
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1029

Analyze bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate?
The IUPAC name of bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate (CID 159677170) is bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate.
What is the SMILES notation for bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate?
The canonical SMILES for bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate is CCOC(=O)c1c(O)c2cnccc2n(Cc2ccc(OC)cc2)c1=O.COc1ccc(Cn2c(=O)c(C#N)c(Cl)c3cnccc32)cc1.COc1ccc(Cn2c(=O)c(C#N)c(Cl)c3cnccc32)cc1.COc1ccc(Cn2c(=O)c(C(=O)NC3CCCCC3)c(O)c3cnccc32)cc1.Cc1ccc(Cn2c(=O)c(C(=O)NC3CCCCC3)c(O)c3cnccc32)cc1.NC1CCCCC1.
What is the InChIKey of bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate?
The InChIKey is MUTBBYDOQYMWBX-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25N3O4.C23H25N3O3.C19H18N2O5.2C17H12ClN3O2.C6H13N/c1-30-17-9-7-15(8-10-17)14-26-19-11-12-24-13-18(19)21(27)20(23(26)29)22(28)25-16-5-3-2-4-6-16;1-15-7-9-16(10-8-15)14-26-19-11-12-24-13-18(19)21(27)20(23(26)29)22(28)25-17-5-3-2-4-6-17;1-3-26-19(24)16-17(22)14-10-20-9-8-15(14)21(18(16)23)11-12-4-6-13(25-2)7-5-12;2*1-23-12-4-2-11(3-5-12)10-21-15-6-7-20-9-14(15)16(18)13(8-19)17(21)22;7-6-4-2-1-3-5-6/h7-13,16,27H,2-6,14H2,1H3,(H,25,28);7-13,17,27H,2-6,14H2,1H3,(H,25,28);4-10,22H,3,11H2,1-2H3;2*2-7,9H,10H2,1H3;6H,1-5,7H2.
What are the key properties of bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate?
bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate has a molecular weight of 1903.99 g/mol, XLogP of 16.31, 20 rotatable bonds, 6 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for bis(4-chloro-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carbonitrile);cyclohexanamine;N-cyclohexyl-4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;N-cyclohexyl-4-hydroxy-1-[(4-methylphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxamide;ethyl 4-hydroxy-1-[(4-methoxyphenyl)methyl]-2-oxo-1,6-naphthyridine-3-carboxylate is sourced from PubChem (CID 159677170), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).